If you have chronic migraine headaches and cannot take other medications, you may be wondering: can you use Aimovig and Botox together? This article will cover the benefits and side effects of these medications. The American Academy of Neurology has also endorsed Botox. It is recommended that the two medications be used together to treat migraine headaches. They can also cause severe side effects.
Side effects of Aimovig
Botox and Aimovig are not comparable in clinical trials. Both medications have proven effective for chronic migraine headaches. After three months of treatment, 40% of patients with chronic migraine experienced fewer headache days. Botox reduced headache days in 24 weeks by an average of 9.2 days a month compared with nonusers. Both are brand names but not available in generic form.
Aimovig side effects are generally minor. However, botosx may cause serious side effects. Even though serious side effects are uncommon, it is important to consult your doctor if you have any concerns. For example, if you have high blood pressure, you may experience an increase in pressure while taking Aimovig. Your doctor might recommend a different medication, or another treatment.
Side effects of Botox
It is possible to wonder what to expect when you are using aimovig. Botox injections are administered in the doctor’s office to patients once every 12 week. The procedure includes 31 tiny injections. Botox, Aimovig and Botox have very similar side effects. Botox injections might be helpful if you suffer from migraines.
Botox injections don't have any side effects. However the possibility of muscle weakness or eyelid ptosis as well as neck pain are possible. Although these side effects generally disappear after a few months, they can still affect patient compliance. Botox treatment requires that you receive injections approximately every 12 weeks. The injections may be painful and will require a cold compress to last for several days.
Side effects of CGRP mAbs
Side effects of CGRP inhibitions have been observed in a handful of clinical trials. But they are not widespread. Many patients were also affected by other inflammatory comorbidities. Some even experienced an unexpected aggravation of an already existing disease. While some patients were considered to be at risk, it is not clear if this was the case for others. Due to a lack of information regarding drug-drug interactions, CGRP inhibitors and other inflammatory comorbidities have led to a cautious approach. Physician awareness of this risk group is essential to ensure safety of CGRP inhibitors, and patient registries are needed to identify patients at risk.
CGRP mAbs can cause severe flares in arthritic and psoriatic conditions. Both psoriatic arthritis and psoriasis are characterized by two distinct phases of inflammatory processes. During the initiating phase, keratinocytes secrete antimicrobial peptides that stimulate plasmacytoid dendritic cells. These peptides encourage myeloid dendritic cell maturation and differentiation into TH1 cells and TH17. Activated myeloid cells promote inflammation by moving to lymph nodes.
Combination therapy can have side effects
Botox and Aimovig are prescription drugs that can be used to treat migraine headaches. Aimovig is an intramuscular injection given once every 12 weeks. These medications both have similar side effects. Combining them can lead to serious side effects. You should talk to your doctor if you are interested in using one of these drugs. In the meantime, learn about the risks associated with each treatment.
Botox has been approved by the FDA to treat chronic migraines in adults. It requires at least 31 injections, and it is repeated every three to four months. While there are no side effects to the treatment, it can cause temporary muscle weakness as well as decrease compliance. It affects the release neurotransmitters like CGRP. Combining botox with it can lead to muscle weakness.